What does CUSIP 86150R107 represent in this 13F holders report?

CUSIP 86150R107 is the security identifier for STOK - Stoke Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held STOK - Stoke Therapeutics, Inc. - Common Stock in Q2 2023?

98 institutional investors reported STOK - Stoke Therapeutics, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Stoke Therapeutics, Inc. - Common Stock (STOK)

CUSIP: 86150R107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 57,529,259
Total 13F shares: 46,534,137
Share change: +1,913,279
Total reported value: $494,657,865
Put/Call ratio: 5.6%
Price per share: $10.63
Number of holders: 98
Value change: +$21,008,744
Number of buys: 55
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 86150R107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Skorpios Trust	13F	Company	25%	14,443,681	$120,315,863	—	31 Mar 2023	13F
RTW INVESTMENTS, LP	13F	Company	7.6%	4,390,558	$36,573,348	—	31 Mar 2023	13F
Redmile Group, LLC	13F	Company	7.2%	4,145,396	$34,531,149	—	31 Mar 2023	13F
COWEN AND COMPANY, LLC	13F	Company	5.7%	3,279,142	$27,315,252	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	5.1%	2,924,528	$24,361,318	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	3.7%	2,115,416	$17,621,415	—	31 Mar 2023	13F
FMR LLC	13F	Company	3.4%	1,968,211	$16,395,197	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	3.2%	1,845,495	$15,372,972	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2%	1,131,987	$9,429,452	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	1.9%	1,087,807	$9,061,000	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	1.2%	716,917	$5,971,919	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	1%	603,524	$5,027,355	—	31 Mar 2023	13F
M28 Capital Management LP	13F	Company	0.93%	532,890	$4,438,974	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.85%	486,680	$4,054,044	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.73%	421,628	$3,512,161	—	31 Mar 2023	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.68%	393,000	$3,273,690	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.66%	377,801	$3,148,000	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	293,632	$2,445,748	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	0.43%	250,000	$2,083,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.39%	224,465	$1,869,794	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.35%	200,897	$1,673,472	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.34%	196,781	$1,639,185	—	31 Mar 2023	13F
Octagon Capital Advisors LP	13F	Company	0.32%	185,669	$1,546,623	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	167,529	$1,396,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.28%	163,715	$1,363,746	—	31 Mar 2023	13F
Trexquant Investment LP	13F	Company	0.22%	125,625	$1,046,456	—	31 Mar 2023	13F
Simplify Asset Management Inc.	13F	Company	0.21%	122,796	$1,022,891	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.2%	114,467	$954,000	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.17%	97,024	$808,210	—	31 Mar 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.16%	92,356	$769,325	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.16%	89,582	$746,218	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	82,172	$684,492	—	31 Mar 2023	13F
Fort Point Capital Partners LLC	13F	Company	0.13%	75,429	$628,324	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.12%	69,440	$578,000	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.12%	68,195	$568,064	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.11%	65,969	$549,522	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.11%	65,700	$547,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	56,059	$467,000	—	31 Mar 2023	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.09%	51,937	$432,635	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.09%	51,935	$432,619	—	31 Mar 2023	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.08%	45,152	$376,116	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.07%	40,364	$336,000	—	31 Mar 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.07%	39,055	$325,328	—	31 Mar 2023	13F
PDT Partners, LLC	13F	Company	0.06%	35,836	$298,514	—	31 Mar 2023	13F
ALGERT GLOBAL LLC	13F	Company	0.06%	34,848	$290,000	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	34,800	$289,884	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	34,597	$288,000	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.06%	34,100	$284,053	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.06%	33,487	$278,947	—	31 Mar 2023	13F
ALPS ADVISORS INC	13F	Company	0.05%	29,085	$242,278	—	31 Mar 2023	13F

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2023

As of 30 Jun 2023, Stoke Therapeutics, Inc. - Common Stock (STOK) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,534,137 shares. The largest 10 holders included Skorpios Trust, RTW INVESTMENTS, LP, Redmile Group, LLC, COWEN AND COMPANY, LLC, MORGAN STANLEY, FMR LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and Cormorant Asset Management, LP. This page lists 98 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.